This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

Chart Advisor: Customer Base


Visit: Investopedia

Wednesday, June 9th, 2021

1/ Biden administration’s big vaccine announcement 

2/ Poised for a trend change

3/ Investors respond to the results 

4/ The bottom line

1/ Biden Administration’s Big Vaccine Announcement 

While investors continue to hesitate at buying up higher share prices, at least one company’s stock price jumped higher on anticipation of a new round of customers. Pfizer Pharmaceuticals (PFE) closed higher by more than 2% on expectations that the Biden administration will announce that half a billion new vaccine doses will be distributed worldwide.  

The chart below shows that PFE jumped higher. That’s not a big surprise. But what is a surprise is that the other two companies known for producing COVID-19 vaccines have such a different price action preceding this news. Johnson & Johnson (JNJ) and Moderna (MRNA) also jumped 2% higher on the news. The move curtailed J&J’s recent downward trend but came after MRNA had already made a substantial upward swing.   

The uneven price action suggests that not all three of these companies will benefit the same from any governmental activity that gets announced tomorrow.

2/ Poised For a Trend Change 

Thor Industries (THO), a recreational vehicle maker, has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average rise for the last two quarters was 44.58%. Reported earnings for this quarter had a surprise of over 40% above expectations. What’s interesting to note is that the stock sold off despite the beat.  

Previously THO’s earning’s per share (EPS) of +6.65% suggested that analysts had grown bullish on its near-term earnings potential. Even though THO beat estimates, coming in at $3.39 per share against the estimated $2.34, investors have taken this opportunity to sell the news.

Thor Industries has seen plenty of overhead resistance over the past three months, and it isn’t keeping up with State Street’s Consumer Discretionary Sector ETF (XLY). This makes a good explanation of why THO shares sold off although earnings were surprisingly positive.  

3/ Investors Respond To the Results 

The Lovesac Company (LOVE) is a technology-driven, omnichannel company that designs, manufactures and sells furniture. The rapid consumer shift to e-commerce has dramatically benefited Lovesac’s millennial-oriented furniture business. Now, as retail stores are beginning to reopen, Lovesac is well positioned.  

LOVE announced earnings today after market close. There was an expected loss of $0.58 per share. The stock moved higher today as these key numbers topped expectations coming in at +$0.13 per share.  

Although the stock has outpaced XLY, it will be interesting to see if it sustains an uptrend in the post-pandemic world. 

4/ The Bottom Line 

Stocks related to the COVID-19 vaccine rose unevenly today suggesting that not all will benefit with the increase of available doses. Thor beat earnings but sold off anyway while Lovesac held onto its upward trend.  

Originally posted on 9th June, 2021

Disclosure: Investopedia The comments, opinions and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or to adopt any investment strategy.  While we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described on our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment or strategy. This information is intended for US residents only.

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Investopedia and is being posted with permission from Investopedia. The views expressed in this material are solely those of the author and/or Investopedia and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

trading top